Create account

Coverage dated October 27, 2026

Study finds common supplement eases common skin condition

Headline from WFMZ Allentown

Scientists say the vitamin derivative pantethine showed “encouraging” results for reducing skin inflammation due to psoriasis.

WFMZ Allentown's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

3 articles, oldest first.

  1. MedicalXpress

    Common nutritional supplement may boost psoriasis treatment, small patient trial suggests (opens MedicalXpress)

    Published

    MedicalXpress's feed description

    Researchers in China have discovered that the vitamin B5 derivative pantethine limits the activity of immune cells that are key contributors to autoimmune diseases such as psoriasis. The study, published in the Journal of Experimental Medicine, shows that pantethine prevents the development of psori…

  2. Geneng News

    Vitamin Derivative Pantethine Alleviates Psoriasis Symptoms in Small Human Trial (opens Geneng News)

    Published

    Geneng News's feed description

    Researchers found that the vitamin B5 derivative pantethine prevented the development of psoriasis in mice, and in a small-scale trial in human psoriasis patients administering pantethine in combination with topical calcipotriol/betamethasone dipropionate helped to alleviate symptoms.

  3. WFMZ Allentown

    Study finds common supplement eases common skin condition (opens WFMZ Allentown)

    Published

    WFMZ Allentown's feed description

    Scientists say the vitamin derivative pantethine showed “encouraging” results for reducing skin inflammation due to psoriasis.

Study finds common supplement eases common skin condition | Since Then